News for Exopharm Limited (EX1.AX)

Recently-listed biotech company Tryptamine Therapeutics (ASX: TYP) has successfully completed the world’s first dosing of a patient with intravenous

The ASX200 didn’t seem to be able to recover from the CPI inflation data April read – showing a rise to 3.6 per cent – which was hotter than many had forecast. The index lost more than 1.15 per cent – all sectors were down with Consumer Staples, Industrials and Financials suffering the most.

Tryp Therapeutics, Inc. announces, that it has filed amended financial statements for the six months ended February 29, 2024 , along with the corresponding Management Discussion & Analysis . The...

Tryp Therapeutics Inc. has announced that further to the press release dated February 8, 2024, the shareholders of Exopharm Limited ACN 163 765 991 have approved the previously announced plan of...

Biotech tends to follow a four to five year market cycle and…

Canadian psychedelics biotech Tryp Therapeutics Inc. has entered into an agreement with Australian publicly-trading drug vehicle developer Exopharm Ltd. for the acquisition of 100% of Tryp’s issued and outstanding common shares.

At the end of a crazy week, it's the goldies out in front again, more than 3.0% better than the ASX benchmark's -1.09% fizzer.

ASX copper stocks going cheap with a sub $30m market cap, the ASX Tech sector is suddenly the place to be, and the top 50 ASX miners and explorers for April.

The ASX crumbled to a -0.92% close after what can only be described as a 25 basis point mugging at the hands of the RBA Board this afternoon.

The ASX opened lower, landing at -0.2% at lunchtime, Pinnacle went soaring until the ASX said 'stop' and Coolabah's been shopping in Canada.

The S&P ASX 200 gained 1.85% in April 2023, extending its YTD gain to 5.38% with mid and small caps outperforming their blue-chip peers.

Some ASX stocks to go to war with, some very bullish gold hedges, and who won the ASX in April?

After a solid +0.8% start, the ASX sagged to a 0.35% close, while Small Cappers Lincoln Minerals and Optima went flying on no news at all.

Aussie markets have opened higher, hitting +0.56% at lunchtime, with WA1 Resources resuming its climb towards +1000% for the year. Wow.

On Stockhead: SILK Laser and assorted ASX beauty stocks are making the most of 'The Lipstick Effect' - a sales surge coined by Estée Lauder.

Market closes flat while Pinnacle Minerals (ASX:PIM) has soared 24% after accidentally discovering rare earths at the Disruptor Prospect.

On Stockhead today, There's 14 lithium plays who now call a US mega-factory neighbour. It's Part 1 of a new Nearology series by Emma Davies.

The ASX closes lower on the final trading day before Easter but don't feel too despondent with markets up for the short four-day week.

The ASX is heading wearily into the long weekend, but Western Mining Group is still piling on the gains. Lots of gains.